MOLINA ARTURO MD — SEC insider filings
SEC reporting owner CIK 1398940. 25 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2020-09-28 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 11 filings — 142,532 shares, $9,179,337 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 57.
- Largest priced transaction: sale of 30,514 shares @ $55.74 ($1,700,850) in Protagonist Therapeutics, Inc, filed 2025-03-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 16 | — | 17 legs · 142,532 sh · $9,179,337 | 31 |
| SUTRO BIOPHARMA, INC. (STRO) | Chief Medical Officer | 6 | — | — | 19 |
| Forma Therapeutics Holdings, Inc. (FMTX) | Director | 3 | — | — | 7 |
Insider filings — MOLINA ARTURO MD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 2,718 @ $124.65 | EDGAR |
| 2026-03-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 15,000 @ $8.04 · Sale (S): 15,000 @ $104.79 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 13,151 @ $82.42 · Option exercise (M): 5,000 @ $8.04 · Sale (S): 5,000 @ $82.28 · Option exercise (M): 5,000 @ $8.04 · Sale (S): 5,000 @ $82 · Option exercise (M): 5,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-21 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 9,514 @ $82.48 | EDGAR |
| 2026-01-06 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 25,600 @ $0 · Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 2,712 @ $84.77 | EDGAR |
| 2025-06-11 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 10,000 @ $8.04 · Sale (S): 10,000 @ $55.51 · Option exercise (M): 10,000 @ $8.04 · Sale (S): 10,000 @ $57.03 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 28,437 @ $23.42 · Option exercise (M): 2,077 @ $38.98 · Sale (S): 30,514 @ $55.74 · Option exercise (M): 28,437 (derivative) @ $0 · Option exercise (M): 2,077 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 388 @ $0 · Sale (S): 3,252 @ $0 | EDGAR |
| 2025-01-06 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 41,088 @ $0 · Grant/award (A): 49,862 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 5,529 @ $8.04 · Sale (S): 5,529 @ $45.60 · Option exercise (M): 10,000 @ $8.04 · Sale (S): 10,000 @ $44.50 · Option exercise (M): 16,000 @ $8.04 · Sale (S): 16,000 @ $44.83 · +3 more | EDGAR |
| 2024-11-19 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 1,906 @ $40.98 | EDGAR |
| 2024-01-18 | 4 | Protagonist Therapeutics, Inc (PTGX) | Tax withholding (F): 427 @ $24.63 | EDGAR |
| 2024-01-04 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 1,848 @ $16.24 · Grant/award (A): 26,250 @ $0 · Grant/award (A): 97,500 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 3,125 @ $0 · Grant/award (A): 18,750 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 21,250 @ $0 · Grant/award (A): 127,500 (derivative) @ $0 | EDGAR |
| 2022-10-14 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Code (U): 10,000 · Disposition to issuer (D): 16,750 (derivative) · Disposition to issuer (D): 6,750 (derivative) | EDGAR |
| 2022-06-09 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Grant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2022-03-07 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 12,500 · Tax withholding (F): 4,355 @ $8.17 · Grant/award (A): 52,000 (derivative) @ $0 · Grant/award (A): 39,000 (derivative) @ $0 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 5,250 @ $0 · Tax withholding (F): 2,151 @ $10.39 · Option exercise (M): 5,250 (derivative) @ $0 | EDGAR |
| 2022-01-13 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Grant/award (A): 5,500 @ $0 · Grant/award (A): 16,750 (derivative) @ $0 | EDGAR |
| 2021-09-28 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 8,609 @ $0 · Tax withholding (F): 2,976 @ $19.23 · Option exercise (M): 8,609 (derivative) @ $0 | EDGAR |
| 2021-03-08 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2021-02-01 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 5,250 @ $0 · Tax withholding (F): 2,107 @ $22.15 · Option exercise (M): 5,250 (derivative) @ $0 | EDGAR |
| 2020-09-28 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 8,609 @ $0 · Tax withholding (F): 2,976 @ $10.30 · Option exercise (M): 8,609 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1398940 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs